ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis

Zhang, Ying; Feng, Weidong; Peng, Xuan; Zhu, Liya; Wang, Zebin; Shen, Hua; Chen, Chaojiang; Xiao, Long; Li, Shuting; Zhao, Yunyi; Lin, Muyi; Huang, Ying*; Long, Haibo*; Liang, Jianbo*广州医学院; 南方医科大学; 中山大学; 1; y
Laboratory Investigation2022-12DOI: 10.1038/s41374-022-00834-3
13被引14阅读
引用收藏
分享

摘要

Peritoneal fibrosis is a common complication of peritoneal dialysis (PD) with a complicated pathogenesis and limited treatments. Parthenolide (PTL), a recognized nuclear factor-kappa B (NF-kappa B) inhibitor extracted from Tanacetum balsamita, has been widely used to treat various inflammatory diseases and has been proven to improve peritoneal fibrosis in PD mice by selectively inhibiting the phosphorylation of Smad2/3. Transforming growth factor-beta 1 (TGF-beta 1), via Smad-dependent signaling, has a pivotal role in promoting pathogenic of fibrosis. To investigate whether PTL can inhibit peritoneal fibrosis, we affected the interaction between NF-kappa B and the TGF-beta/Smad2/3 pathway. Long dwell peritoneal dialysis fluid (PDF) and peritoneum tissues were collected from continuous ambulatory peritoneal dialysis (CAPD) patients. PTL was administered intragastrically into a PD mouse model by daily infusion of 4.25% dextrose-containing PDF. Treated HMrSV5 cells or rat peritoneal mesothelial cells (RPMCs) were treated with high glucose(138 mM) at the same concentration as 2.5% dextrose-containing PDF and PTL. PD-related peritoneal fibrosis samples indicated an increase in inflammation, and PTL decreased the levels of inflammatory cytokines (L-6, TNF-alpha, and MCP-1). PTL inhibited high glucose-induced mesothelial-to-mesenchymal transition (MMT), as indicated by a reduced expression of fibrosis markers (fibronectin, collagen I, and alpha-SMA) and increased expression of the epithelial marker E-cadherin. PTL also significantly decreased TGF-beta 1 expression and the phosphorylation of I kappa B alpha and NF-kappa Bp65. The changes in the levels of TGF-beta 1 expression and p-p65 or p65 showed similar trends according to western blot, immunohistochemistry, and immunofluorescence assays in vitro and in vivo. Chromatin immunoprecipitation (ChIP) and luciferase reporter assays were used to confirm that PTL regulates the transcription of TGF-beta 1 induced by high glucose through NF-kappa Bp65. In summary, PTL induces a therapeutic effect in peritoneal fibrosis by inhibiting inflammation via the NF-kappa B/ TGF-beta/Smad signaling axis.

学科与关键词

关键词
TRANSCRIPTION FACTORSESQUITERPENE LACTONESDIALYSISBETAHEMODIALYSISMEMBRANEPATHWAY
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Laboratory Investigation
发表日期
2022-12
卷期
第 102 卷, 第 12 期
页码
1346-1354
DOI
10.1038/s41374-022-00834-3
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Medical Scientific Research Foundation of Guangdong Province, China [A2021398]; Basic and Applied Basic Research Foundation of Guangdong Province, China [2022A1515012665]; National Natural Science Foundation of China (NSFC) [81800612]; Natural Science Foundation of Guangdong Province, China [2020A1515011295]; University Scientific Research Project of Guangzhou Education Bureau [201831833]

作者

  • Z

    Zhang, Ying (第一作者)

    2 · guangzhou med univ

  • F

    Feng, Weidong

    1 · sun yat sen univ

查看全部 14 位作者收起作者
  • P

    Peng, Xuan

    2 · guangzhou med univ

  • Z

    Zhu, Liya

    2 · guangzhou med univ

  • W

    Wang, Zebin

    2 · guangzhou med univ

  • S

    Shen, Hua

    2 · guangzhou med univ

  • C

    Chen, Chaojiang

    2 · guangzhou med univ

  • X

    Xiao, Long

    2 · guangzhou med univ

  • L

    Li, Shuting

    southern med univ

  • Z

    Zhao, Yunyi

    2 · guangzhou med univ

  • L

    Lin, Muyi

    2 · guangzhou med univ

  • H

    Huang, Ying (通讯)

    2 · guangzhou med univ

  • L

    Long, Haibo (通讯)

    southern med univ

  • L

    Liang, Jianbo (通讯)

    2 · guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417